Bladder Cancer
Bladder cancer recurrence risk predicted by E-cadherin promoter polymorphism
Published in Cancer Weekly, October 17th, 2006
According to recent research from the United States, "Tumor recurrence is a hallmark of superficial bladder cancer. Currently, a molecular marker for bladder cancer recurrence is lacking."
"E-cadherin plays an important role in epithelial development and in the establishment and maintenance of cell-cell adhesion and tissue architecture," explained J. Lin and colleagues, M.D. Anderson Cancer Center. "The purpose of this study is to investigate the association of an E-cadherin promoter polymorphism with the risk of bladder cancer recurrence. This study...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-10-17)
More Articles from Cancer Weekly
- Breast Cancer
Breast cancer growth stimulated by Essiac and Flor-Essence herbal tonics - Cancer Incidence
Increased cancer incidence not associated with fluvastatin treatment - Colorectal Cancer
Colorectal cancer progression predicted by sarco/endoplasmic reticulum calcium-ATPase 2 expression - Spinal Bone Metastases
Spinal bone metastases survival prediction model developed and validated - Acute Myeloid Leukemia
Acute myeloid leukemia-associated MLL partial tandem duplications persist lifelong - Adverse Drug Reaction
Cancer chemotherapy-induced diarrhea and constipation discussed - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
